Poisson regression for cancer-specific mortality and all-cancer mortality among Moluccan–Dutch, adjusted for age-at-baseline and socioeconomic status
| Cancer type | N | Both sexes | N | Males | N | Females |
| RR (95% CI) | RR (95% CI) | RR (95% CI) | ||||
| Stomach | 33 | 0.71 (0.50 to 1.00) | 17 | 0.57 (0.35 to 0.91) | 16 | 0.96 (0.59 to 1.57) |
| Liver | 53 | 2.60 (1.98 to 3.42) | 33 | 2.58 (1.83 to 3.64) | 20 | 2.65 (1.69 to 4.17) |
| Cervix | 15 | – | – | – | 15 | 1.89 (1.13 to 3.14) |
| Colorectal | 138 | 0.95 (0.80 to 1.12) | 81 | 1.01 (0.81 to 1.26) | 57 | 0.87 (0.67 to 1.13) |
| Breast | 134 | – | – | – | 134 | 1.08 (0.91 to 1.29) |
| Prostate | 79 | – | 79 | 1.21 (0.97 to 1.51) | – | – |
| Bladder | 27 | 0.75 (0.51 to 1.10) | 16 | 0.64 (0.39 to 1.05) | 11 | 1.03 (0.55 to 1.91) |
| Lung and lower airway | 336 | 0.95 (0.85 to 1.05) | 201 | 0.90 (0.78 to 1.03) | 135 | 1.00 (0.84 to 1.19) |
| Oesophagus | 25 | 0.46 (0.31 to 0.68) | 23 | 0.55 (0.37 to 0.83) | <10 | 0.15 (0.04 to 0.62) |
| Corpus uteri | 22 | – | – | – | 22 | 1.72 (1.12 to 2.64) |
| Ovaries | 40 | – | – | – | 40 | 1.19 (0.87 to 1.63) |
| Pancreas | 62 | 0.86 (0.67 to 1.11) | 24 | 0.63 (0.42 to 0.95) | 38 | 0.13 (0.82 to 1.55) |
| Kidney | 20 | 0.61 (0.39 to 0.96) | 14 | 0.70 (0.41 to 1.18) | <10 | 0.46 (0.19 to 1.11) |
| Leukaemia | 48 | 1.21 (0.89 to 1.65) | 25 | 1.17 (0.77 to 1.76) | 23 | 1.27 (0.80 to 2.02) |
| Non-Hodgkin’s lymphoma | 48 | 1.29 (0.96 to 1.73) | 35 | 1.60 (1.13 to 2.27) | 13 | 0.84 (0.48 to 1.49) |
| Nervous system | 19 | 0.32 (0.18 to 0.58) | 11 | 0.30 (0.13 to 0.66) | <10 | 0.36 (0.15 to 0.86) |
| All cancers (ICD-10 codes C00–D48) | 0.98 (0.93 to 1.03) | 0.92 (0.85 to 0.99) | 1.05 (0.97 to 1.13) |
N<10 is not shown in accordance with Statistics Netherlands (CBS) guidelines.
ICD-10, 10th revision of the International Statistical Classification of Diseases and Related Health Problems; RR, relative risk.